Investigation of the impact of copper nanoparticles coated with ocimum bassilicum at chemoradiotherapy of colon carcinoma.

Autor: Nejad FS; Molecular Medicine Research Center, Tabriz University of Medical Sciences, Tabriz, Iran.; Department of Radiation Oncology, Faculty of Medicine, Tabriz University of Medical Sciences, Tabriz, Iran., Alizade-Harakiyan M; Department of Radiation Oncology, Faculty of Medicine, Tabriz University of Medical Sciences, Tabriz, Iran.; Medical Physics Department, Faculty of Medicine, Tabriz University of Medical Sciences, Tabriz, Iran., Haghi M; Department of Animal Biology, Faculty of Natural Sciences, University of Tabriz, Tabriz, Iran., Ebrahimi R; Medicinal Chemistry Department, Faculty of Pharmacy, Tabriz University of Medical Sciences, Tabriz, Iran., Zangeneh MM; Department of Animal Biology, Faculty of Natural Sciences, University of Tabriz, Tabriz, Iran.; Biotechnology and Medicinal Plants Research Center, Ilam University of Medical Sciences, Ilam, Iran., Farajollahi A; Department of Radiation Oncology, Faculty of Medicine, Tabriz University of Medical Sciences, Tabriz, Iran.; Medical Physics Department, Faculty of Medicine, Tabriz University of Medical Sciences, Tabriz, Iran.; Medical Radiation Science Research Team, Tabriz University of Medical Sciences, Tabriz, Iran., Fathi R; Polymer Research Laboratory, Department of Organic and Biochemistry, University of Tabriz, Tabriz, Iran., Mohammadi R; Polymer Research Laboratory, Department of Organic and Biochemistry, University of Tabriz, Tabriz, Iran., Miandoab SS; Molecular Medicine Research Center, Tabriz University of Medical Sciences, Tabriz, Iran., Asl MH; Department of Animal Biology, Faculty of Natural Sciences, University of Tabriz, Tabriz, Iran., Divband B; Department of Inorganic Chemistry, Faculty of Chemistry, University of Tabriz, Tabriz, Iran., Ahmadi A; Research Center for Pharmaceutical Nanotechnology, Biomedicine Institute, Tabriz University of Medical Sciences, Tabriz, Iran.

Publikováno v: Biochemistry and biophysics reports [Biochem Biophys Rep] 2024 Jul 06; Vol. 39, pp. 101780. Date of Electronic Publication: 2024 Jul 06 (Print Publication: 2024).

Durvalumab and taxane family combination therapy enhances the antitumoral effects for NSCLC: An in vitro study.

Autor: Firoozi MR; Tuberculosis and Lung Diseases Research Center, Tabriz University of Medical Sciences, Tabriz, Iran., Sadeghi-Mohammadi S; Tuberculosis and Lung Diseases Research Center, Tabriz University of Medical Sciences, Tabriz, Iran., Asadi M; Department of Basic Oncology, Health Institute of Ege University, Izmir, Turkey., Shekari N; Department of Immunology, School of Medicine, Shahid Beheshti University of Medical Sciences, Tehran, Iran., Seyed Nejad F; Department of Radiation Oncology, School of Medicine, Tabriz University of Medical Sciences, Tabriz, Iran., Alizade-Harakiyan M; Department of Radiation Oncology, School of Medicine, Tabriz University of Medical Sciences, Tabriz, Iran., Soleimani Z; Tuberculosis and Lung Diseases Research Center, Tabriz University of Medical Sciences, Tabriz, Iran., Zarredar H; Tuberculosis and Lung Diseases Research Center, Tabriz University of Medical Sciences, Tabriz, Iran.

Publikováno v: Cell biochemistry and function [Cell Biochem Funct] 2024 Jan; Vol. 42 (1), pp. e3919.

The Preventive Effects of Boron-Based Gel on Radiation Dermatitis in Patients Being Treated for Breast Cancer: A Phase III Randomized, Double-Blind, Placebo-Controlled Clinical Trial.

Autor: Sahin F; Physical Medicine and Rehabilitation Research Center, Aging Research Institute, Tabriz University of Medical Sciences, Tabriz, Iran.; Department of Genetics and Bioengineering, Faculty of Engineering, Yeditepe University, Istanbul, Turkey., Pirouzpanah MB; Stem Cell Research Center, Tabriz University of Medical Sciences, Tabriz, Iran., Bijanpour H; Stem Cell Research Center, Tabriz University of Medical Sciences, Tabriz, Iran., Mohammadzadeh M; Department of Radiation Oncology, School of Medicine, Tabriz University of Medical Sciences, Tabriz, Iran., Eghdam Zamiri R; Department of Radiation Oncology, School of Medicine, Tabriz University of Medical Sciences, Tabriz, Iran., Ghasemi Jangjoo A; Department of Radiation Oncology, School of Medicine, Tabriz University of Medical Sciences, Tabriz, Iran., Nasiri B; Department of Radiation Oncology, Tabriz International Hospital, Tabriz, Iran., Saboori H; Department of Radiation Oncology, Tabriz International Hospital, Tabriz, Iran., Doğan A; Department of Genetics and Bioengineering, Faculty of Engineering, Yeditepe University, Istanbul, Turkey., Demirci S; Cellular and Molecular Therapeutics Branch, National Heart Lung and Blood Institutes and National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health, Bethesda, Maryland, USA., Ayşan E; Faculty of Medicine, Department of General Surgery, Yeditepe University, Istanbul, Turkey., Çağrı Büke A; Department of Infectious Diseases, Yeditepe University Hospital, Yeditepe University, Istanbul, Turkey., Naseri AR; Department of Radiation Oncology, School of Medicine, Tabriz University of Medical Sciences, Tabriz, Iran., Shakouri SK; Physical Medicine and Rehabilitation Research Center, Aging Research Institute, Tabriz University of Medical Sciences, Tabriz, Iran., Aghamohammadi D; Physical Medicine and Rehabilitation Research Center, Aging Research Institute, Tabriz University of Medical Sciences, Tabriz, Iran., Alizade-Harakiyan M; Department of Radiation Oncology, School of Medicine, Tabriz University of Medical Sciences, Tabriz, Iran., Seyed Nejad F; Physical Medicine and Rehabilitation Research Center, Aging Research Institute, Tabriz University of Medical Sciences, Tabriz, Iran.; Department of Radiation Oncology, School of Medicine, Tabriz University of Medical Sciences, Tabriz, Iran.; Department of Radiation Oncology, Tabriz International Hospital, Tabriz, Iran.

Publikováno v: Oncology research and treatment [Oncol Res Treat] 2022; Vol. 45 (4), pp. 197-204. Date of Electronic Publication: 2022 Jan 03.

Recent Treatment Strategies and Molecular Pathways in Resistance Mechanisms of Antiangiogenic Therapies in Glioblastoma.

Autor: Rahman, Md Ataur¹ (AUTHOR) rahman23@wayne.edu, Ali, Meser M.¹ (AUTHOR) rahman23@wayne.edu

Publikováno v: Cancers. Sep2024, Vol. 16 Issue 17, p2975. 24p.

Trends in the application of metal Nanobiomaterials in cancer therapy clinical trials.

Autor: Yun, Zhengcheng, Wei, Junfan

Publikováno v: Frontiers in Nanotechnology (2673-3013); 2024, p1-16, 16p